• Nishikawa A, Nagano K, Kojima H, Fukushima S, Ogawa K. Pathogenesis of chemically induced nasal cavity tumors in rodents: contribution to adverse outcome pathway, J Toxicol Pathol. 2024;37(1):11-27. doi: 10.1293/tox.2023-0098
  • Aoi T, Asaka I, Akutsu H, Ito Y, Kataoka K, Kanda Y, Kojima H, Sekino Y, Suemori H, Nakagawa M, Nakamura K, Nakamura Y, Fujii M, Furue M, Yamazaki D, Japanese Working Group for Consideration of Good Cell Culture Practice: Secondary Publication: Proposal for Points of Consideration for Pluripotent Stem Cell Culture, In Vitro Cellular & Developmental Biology – Animal. 12 March 2024.
  • Yamamoto N, Hiramatsu N, kato Y, Sato A, Kojima H, Development of an Eye Irritation Test Method Using anIn‑House Fabrication of a Reconstructed Human Cornea‑like Epithelium Model for Eye Hazard Identification, IBioengineering, 2024;11(4):302.
  • Ashikaga T, Hatano K, Iwasa H, Kinoshita K, Nakamura N, Ambe K, Tohkin M, Next Generation Risk Assessment Case Study: A Skin Sensitization Quantitative Risk Assessment for Bandrowski’s Base Existing in Hair Color Formulations, J. Cos. Sci. Soc, 2024;48(2):1-5.
  • 誌上発表(総説)


    • 小島肇夫: "化学物質の複合影響と健康リスク評価"第1章 第5節 AOPアプローチ, 編者:青木康展、青山博昭, 医歯薬出版(株), 東京, pp.51-63(2024).


    • Kojima H: Japanese Regulatory activities on 3D cell culture, International Conference on Advances in 3D Cell Culture (2024.2.3, Mumbai, India)
    • 安部賀央里, 木下啓, 山田隆志, 足利太可雄, 頭金正博: 皮膚感作性評価におけるin silico予測モデルの開発, 第10回CBI学会 個別化医療研究会 (2024.2.27, 岐阜)
    • Ashikaga T, Ohno A, Arai R, Iijima K: Activation of THP-1 cells by mixed exposure to silicon dioxide nanomaterial and skin sensitizer or febrile substance, SOT 63nd Annual Meeting(2024.3.12, Salt Lake City, USA)
    • 足利太可雄, 奥 輝明: 発熱性物質試験法に代わる迅速で簡便なMonocyte Activation Test(MAT)-ウサギから組換え細胞へー, 日本薬学会第144年会 (2024.3.30, 横浜)
    • 足利太可雄: 免疫毒性に関するAOPおよびOECDテストガイドラインの開発状況, 日本薬学会第144年会 (2024.3.30, 横浜)
    • Ishida S, Matsushita T, Sato K, Ashikaga T, Hirabayashi Y, Yamazaki D: Japanese approach to the proposal of an OECD Test Guideline using Gut-Liver MPS for the first pass effect analysis as a Context of Use of toxicokinetic simulator in chemical risk assessment, MPS World Summit 2024 (2024.6.13, Seattle, USA)